| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0301-2115(97)00146-2 |
| P698 | PubMed publication ID | 9481543 |
| P50 | author | Hans Wolf | Q41277661 |
| P2093 | author name string | Treffers PE | |
| van der Post JA | |||
| Bonsel GJ | |||
| van Pampus MG | |||
| Westenberg SM | |||
| P2860 | cites work | Spontaneous resolution of pre-eclampsia-related thrombocytopenia | Q33356844 |
| HELLP syndrome--a syndrome of hemolysis, elevated liver enzymes and low platelet count--complicating preeclampsia-eclampsia. | Q33371904 | ||
| The natural history of HELLP syndrome: patterns of disease progression and regression | Q33389693 | ||
| The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? | Q33404012 | ||
| Elevated liver enzymes and thrombocytopenia in the third trimester of pregnancy: an unusual case report and a review of the literature | Q33428607 | ||
| Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy | Q33484095 | ||
| Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome) | Q34344424 | ||
| Influence of obstetric management on outcome of extremely preterm growth retarded infants. | Q35285954 | ||
| Clinical outcome of small for gestational age preterm infants | Q43439240 | ||
| Temporising management of severe pre-eclampsia with and without the HELLP syndrome | Q46362894 | ||
| Perinatal results of hemodynamic and conservative temporizing treatment in severe pre-eclampsia. | Q46364426 | ||
| Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia | Q46377642 | ||
| Fetal distress due to placental insufficiency at 26 through 31 weeks: a comparison between an active and a more conservative management | Q73070585 | ||
| P433 | issue | 1 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| HELLP syndrome | Q1563513 | ||
| maternal health | Q6786626 | ||
| P304 | page(s) | 31-36 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | European Journal of Obstetrics Gynecology and Reproductive Biology | Q15755730 |
| P1476 | title | Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome | |
| P478 | volume | 76 |
| Q46331247 | An analysis of HELLP syndrome cases: does platelet count predict adverse maternal and fetal outcomes in women with HELLP syndrome? |
| Q46330893 | Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome? |
| Q33400357 | Comparison of maternal and neonatal outcomes in women with HELLP syndrome and women with severe preeclampsia without HELLP syndrome |
| Q47683873 | Conservative versus active management in HELLP syndrome: results from a cohort study |
| Q33579089 | Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013). |
| Q33329194 | Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity |
| Q46353872 | Effect of corticosteroids on HELLP syndrome: a case report |
| Q33334624 | HELLP syndrome |
| Q43672726 | HELLP syndrome in the 18th week of gestation in association with elevated angiotensin AT(1)-receptor autoantibodies |
| Q33292245 | Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial. |
| Q47857696 | Is there a diurnal pattern in the clinical symptoms of HELLP syndrome? |
| Q43664484 | MOS HIP: McMaster outcome study of hypertension in pregnancy |
| Q34224924 | Management and monitoring of severe preeclampsia |
| Q38486673 | Maternal and feto-placental phenotypes of early-onset severe preeclampsia |
| Q46354706 | Maternal outcome following temporizing management of the (H)ELLP syndrome |
| Q37206839 | Neonatal outcome after preterm delivery in HELLP syndrome |
| Q46346779 | Neonatal outcome in pregnancies after preterm delivery for HELLP syndrome |
| Q38263967 | Outcomes of expectant management after betamethasone for hypertensive disorders of pregnancy |
| Q104137018 | Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction |
| Q21261342 | The HELLP syndrome: clinical issues and management. A Review |
| Q46348899 | The HELLP-syndrome; maternal-fetal outcome and follow up of infants |
| Q33337048 | Time course of recovery and complications of HELLP syndrome with two different treatments: heparin or dexamethasone |
| Q34257837 | Treating hypertension in women of child-bearing age and during pregnancy |
Search more.